Embry Holdings Reports HK$58 Million Loss Attributable to Owners for H1 2025 Despite HK$604.5 Million Revenue; E-commerce Sales Up 7.6% Year-on-Year

Reuters
08/29
Embry Holdings Reports HK$58 Million Loss Attributable to Owners for H1 2025 Despite HK$604.5 Million Revenue; E-commerce Sales Up 7.6% Year-on-Year

Embry Holdings Limited has announced its unaudited condensed consolidated results for the six months ended 30 June 2025. The company's revenue stood at approximately HK$604.5 million, a decrease from HK$631.4 million reported for the corresponding period in 2024. Gross profit for the period was approximately HK$442.3 million, down from HK$478.3 million in the prior period. The company recorded a loss attributable to owners of approximately HK$58.0 million, influenced by non-recurring, unrealised, and non-cash items totaling approximately HK$22.1 million. E-commerce sales saw an increase of 7.6% year-on-year, reaching HK$236.8 million. The Chinese Mainland market remains the main source of income, contributing HK$582.5 million, representing 96.4% of the Group's total revenue. The flagship brand, EMBRY FORM, contributed 64.7% of the total revenue, amounting to HK$391.1 million, up by 1.5% from the prior period. The company intensified promotional activities in the second quarter, leading to an improvement in offline retail performance with a reduced rate of decline compared to the first quarter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Embry Holdings Limited published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10